Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Masquelier

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Progress in Clinical and Biological Research|January 1, 1982
Drug targeting in cancer treatment: active daunorubicin-protein conjugatesD Deprez-de Campeneere, M Masquelier, R Baurain, et al.
British Journal of Cancer|November 1, 1990
Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complexS Vitols, K Söderberg-Reid, M Masquelier, et al.
Cancer Research|January 1, 1990
On the paradoxically concentration-dependent metabolism of 6-mercaptopurine in WEHI-3b murine leukemia cellsJ Liliemark, B Pettersson, B Engberg, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
DNA, liposomes, and proteins as carriers for antitumoral drugsA Trouet, R Baurain, D Deprez-De Campeneere, et al.
Pathologie-Biologie|May 1, 1989
[Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose]J Guibert, M D Kitzis, J F Acar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2014
Prospective evaluation of venous access difficulty and a near-infrared vein visualizer at four French haemophilia treatment centresP Guillon, M Makhloufi, S Baillie, et al.
Bulletin of the World Health Organization|January 1, 1981
Development of new derivatives of primaquine by association with lysosomotropic carriersA U Trouet, P Pirson, R Steiger, et al.
The American Journal of Medicine|April 6, 1992
A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritisY Mouton, F Ajana, C Chidiac, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 1, 2014
FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registryJ-Y Borg, C Négrier, I Durieu, et al.
Journal of Drug Targeting|August 12, 2000
Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy: study of stability of drug-carrier complexes in bloodM Masquelier, S Vitols, M Pålsson, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Progress in Clinical and Biological Research|January 1, 1982
Drug targeting in cancer treatment: active daunorubicin-protein conjugatesD Deprez-de Campeneere, M Masquelier, R Baurain, et al.
British Journal of Cancer|November 1, 1990
Low density lipoprotein for delivery of a water-insoluble alkylating agent to malignant cells. In vitro and in vivo studies of a drug-lipoprotein complexS Vitols, K Söderberg-Reid, M Masquelier, et al.
Cancer Research|January 1, 1990
On the paradoxically concentration-dependent metabolism of 6-mercaptopurine in WEHI-3b murine leukemia cellsJ Liliemark, B Pettersson, B Engberg, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
DNA, liposomes, and proteins as carriers for antitumoral drugsA Trouet, R Baurain, D Deprez-De Campeneere, et al.
Pathologie-Biologie|May 1, 1989
[Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose]J Guibert, M D Kitzis, J F Acar, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2014
Prospective evaluation of venous access difficulty and a near-infrared vein visualizer at four French haemophilia treatment centresP Guillon, M Makhloufi, S Baillie, et al.
Bulletin of the World Health Organization|January 1, 1981
Development of new derivatives of primaquine by association with lysosomotropic carriersA U Trouet, P Pirson, R Steiger, et al.
The American Journal of Medicine|April 6, 1992
A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritisY Mouton, F Ajana, C Chidiac, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 1, 2014
FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registryJ-Y Borg, C Négrier, I Durieu, et al.
Journal of Drug Targeting|August 12, 2000
Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy: study of stability of drug-carrier complexes in bloodM Masquelier, S Vitols, M Pålsson, et al.
Pageof 3